Susquehanna International Group’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-81,039
| Closed | -$14.9M | – | 14443 |
|
|
2021
Q2 | $14.9M | Buy |
81,039
+52,490
| +184% | +$9.01M | 0.02% | 2378 |
|
|
2021
Q1 | $4.37M | Sell |
28,549
-164,427
| -85% | -$25.4M | 0.01% | 4180 |
|
|
2020
Q4 | $30.2M | Sell |
192,976
-282,353
| -59% | -$36.3M | 0.04% | 1365 |
|
|
2020
Q3 | $54.4M | Buy |
475,329
+173,390
| +57% | +$18.7M | 0.1% | 825 |
|
|
2020
Q2 | $33.9M | Sell |
301,939
-575,642
| -66% | -$61.1M | 0.06% | 1037 |
|
|
2020
Q1 | $78.8M | Buy |
877,581
+381,777
| +77% | +$37.5M | 0.19% | 477 |
|
|
2019
Q4 | $53.6M | Buy |
495,804
+66,769
| +16% | +$7.14M | 0.11% | 775 |
|
|
2019
Q3 | $42M | Buy |
429,035
+288,849
| +206% | +$32.6M | 0.1% | 840 |
|
|
2019
Q2 | $18.4M | Buy |
+140,186
| New | +$18.1M | 0.04% | 1338 |
|
|
2019
Q1 | – | Sell |
-65,654
| Closed | -$8.16M | – | 11075 |
|
|
2018
Q4 | $6.39M | Buy |
65,654
+33,383
| +103% | +$3.95M | 0.03% | 2029 |
|
|
2018
Q3 | $4.49M | Sell |
32,271
-153,358
| -83% | -$19.2M | 0.02% | 2822 |
|
|
2018
Q2 | $23M | Sell |
185,629
-135,271
| -42% | -$15.8M | 0.08% | 1190 |
|
|
2018
Q1 | $35.8M | Buy |
320,900
+87,082
| +37% | +$10.4M | 0.12% | 826 |
|
|
2017
Q4 | $28M | Buy |
233,818
+211,611
| +953% | +$25.8M | 0.09% | 1019 |
|
|
2017
Q3 | $3.12M | Sell |
22,207
-372,967
| -94% | -$50.7M | 0.01% | 3180 |
|
|
2017
Q2 | $48.1M | Buy |
395,174
+197,301
| +100% | +$23M | 0.19% | 627 |
|
|
2017
Q1 | $24M | Sell |
197,873
-164,675
| -45% | -$21.2M | 0.11% | 954 |
|
|
2016
Q4 | $44.4M | Buy |
362,548
+147,742
| +69% | +$18.1M | 0.2% | 607 |
|
|
2016
Q3 | $26.3M | Buy |
214,806
+208,042
| +3,076% | +$26.8M | 0.12% | 840 |
|
|
2016
Q2 | $790K | Sell |
6,764
-5,911
| -47% | -$839K | ﹤0.01% | 5324 |
|
|
2016
Q1 | $1.76M | Sell |
12,675
-3,444
| -21% | -$506K | 0.01% | 4011 |
|
|
2015
Q4 | $3.07M | Sell |
16,119
-106,451
| -87% | -$18.6M | 0.01% | 3235 |
|
|
2015
Q3 | $19.2M | Buy |
122,570
+33,726
| +38% | +$6.15M | 0.04% | 1237 |
|
|
2015
Q2 | $16.1M | Buy |
88,844
+47,865
| +117% | +$8.26M | 0.03% | 1517 |
|
|
2015
Q1 | $7.1M | Sell |
40,979
-28,711
| -41% | -$5.2M | 0.02% | 2260 |
|
|
2014
Q4 | $12.9M | Sell |
69,690
-60,047
| -46% | -$11.1M | 0.03% | 1748 |
|
|
2014
Q3 | $21.5M | Sell |
129,737
-43,302
| -25% | -$7.11M | 0.04% | 1341 |
|
|
2014
Q2 | $27M | Sell |
173,039
-34,691
| -17% | -$5.48M | 0.06% | 1131 |
|
|
2014
Q1 | $31.6M | Buy |
207,730
+132,681
| +177% | +$21.1M | 0.08% | 903 |
|
|
2013
Q4 | $9.99M | Sell |
75,049
-30,078
| -29% | -$3.61M | 0.02% | 2072 |
|
|
2013
Q3 | $12.2M | Sell |
105,127
-60,545
| -37% | -$6.64M | 0.03% | 1686 |
|
|
2013
Q2 | $15.3M | Buy |
+165,672
| New | +$16M | 0.04% | 1363 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM